Roundhouse AI

ClinicalIntelPulse

Medical intelligence API for AI agents. Plain-language drug info, drug-interaction screening, and recall checks from FDA-approved labels, plus pharmaceutical pipeline and clinical-trial intelligence from 400,000+ ClinicalTrials.gov studies. Pay-per-query via x402.

OtherLiveeip155:8453Exactvia cdp
https://clinicalintelpulse.vercel.app/api/clinical/disease-landscape
Disease-landscapePipeline-intelligenceDrug-developmentCompetitive-intelligenceOncology
Settlements · 30d
605↑ 478%
No per-endpoint history for this service yet, so this is payments indexed to its PROVIDER's wallet over 30 days.
$768.65
Verified settled volume
A floor: summed over 5,000 of 11,321 verified settlements.
$0.350
Listed price
As published in the catalog. Always read the live 402 before paying.
1
Calls · 30d
Upstream's own call count for this endpoint, not ours.
1
Unique payers · 30d
Last called 2026-07-01 04:26Z
—
Upstream on-chain volume
Reported by the source catalog.
Paid to
0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc

The wallet the 402 directs payment to. Its whole payment record — every payer, every chain — is on the merchant page.

Asset 0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913

Provider

The payTo wallet does not resolve to a registered ERC-8004 agent. That is not a verdict on the service — most of the catalog is unregistered.

Live 402 challenge

Captured by the enrichment pass, not read just now. Prices can change — always read the 402 the endpoint answers with.

{
  "error": "X-PAYMENT header is required",
  "accepts": [
    {
      "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
      "extra": {
        "name": "USD Coin",
        "version": "2"
      },
      "payTo": "0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc",
      "scheme": "exact",
      "network": "base",
      "mimeType": "application/json",
      "resource": "https://clinicalintelpulse.theaslangroupllc.com/api/clinical/disease-landscape",
      "description": "Competitive drug pipeline landscape for any disease — full Phase 2/3 trial map, mechanism-of-action coverage, approved drugs, PDUFA calendar, M&A activity, opportunity gaps and investment thesis. Worldwide. For biotech and pharma intelligence agents.",
      "maxAmountRequired": "350000",
      "maxTimeoutSeconds": 300
    }
  ],
  "x402Version": 1
}

Accepts

The payment requirements as published to the catalog. Read the live 402 before paying — a price here is a claim, not a quote.

0.35USDC≈ $0.35 USD
on Base · exact scheme

Pay 0.35 USDC on Base to 0x50ab…912fc. The signed payment is good for 5 minutes.

Paid to
0x50ab…912fc
USD Coin contract
0x8335…02913
Payment window
5 minutes
As published
350000 smallest units
350000units
on solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp · exact scheme

That figure is in the token’s smallest units. Roundhouse does not hold this contract’s decimals, so it is shown as published rather than converted.

Paid to
985iFj…B5KX1
Token contract
EPjFWd…TDt1v
Payment window
5 minutes
The catalog’s raw entry
[
  {
    "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
    "extra": {
      "name": "USD Coin",
      "version": "2"
    },
    "payTo": "0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc",
    "amount": "350000",
    "scheme": "exact",
    "network": "eip155:8453",
    "maxTimeoutSeconds": 300
  },
  {
    "asset": "EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v",
    "extra": {
      "feePayer": "GVJJ7rdGiXr5xaYbRwRbjfaJL7fmwRygFi1H6aGqDveb"
    },
    "payTo": "985iFjbnGQ3dJcwXnfRCMSrH4Jnc3kW1N6msR64B5KX1",
    "amount": "350000",
    "scheme": "exact",
    "network": "solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp",
    "maxTimeoutSeconds": 300
  }
]

Extensions

{
  "bazaar": {
    "info": {
      "input": {
        "type": "http",
        "method": "GET",
        "queryParams": {
          "lang": "en | es | fr | de | ja | zh | ko | pt | ar | hi (default: en)",
          "depth": "standard | deep (default: standard)",
          "condition": "Disease area — e.g. \"Parkinson Disease\" | \"Breast Cancer\" | \"NASH\" | \"Heart Failure\" | \"Schizophrenia\""
        }
      },
      "output": {
        "type": "json",
        "example": {
          "deal_activity": "Highly active M&A space. AstraZeneca acquired Eccogene NASH program ($185M). Roche/Genentech building liver portfolio. Novo Nordisk GLP-1 dominance creating competitive panic.",
          "query_summary": {
            "as_of": "2026-06-07",
            "depth": "standard",
            "condition": "NASH (Nonalcoholic Steatohepatitis)"
          },
          "approved_drugs": [
            {
              "name": "Resmetirom (Rezdiffra)",
              "sponsor": "Madrigal Pharmaceuticals",
              "approved": "2024-03",
              "mechanism": "THR-β agonist",
              "indication": "NASH with moderate-to-advanced fibrosis"
            }
          ],
          "pdufa_calendar": [
            {
              "drug": "Lanifibranor",
              "sponsor": "Inventiva",
              "mechanism": "Pan-PPAR",
              "pdufa_estimate": "2026-Q1",
              "priority_review": false
            }
          ],
          "investment_thesis": "NASH market projected $18-25B by 2030. Resmetirom first approval sets pricing precedent. GLP-1 combination therapy is the likely future standard of care.",
          "opportunity_score": {
            "max": 100,
            "note": "Validated market with first approval. GLP-1 expansion threatening narrow competitors.",
            "score": 78,
            "rating": "High Value"
          },
          "pipeline_overview": {
            "phase2_count": 48,
            "phase3_count": 19,
            "total_active": 67,
            "approved_drugs": 2,
            "approval_recent_12m": 1
          },
          "top_phase3_assets": [
            {
              "drug": "Semaglutide 2.4mg",
              "nctId": "NCT04858633",
              "sponsor": "Novo Nordisk",
              "mechanism": "GLP-1 RA",
              "completion": "2025-Q4",
              "significance": "Blockbuster potential — NASH + obesity combined label"
            }
          ],
          "mechanism_landscape": {
            "crowded": [
              "FXR agonists (8 Phase 2/3)",
              "ACC inhibitors (6)",
              "FGF21 analogs (5)"
            ],
            "emerging": [
              "Pan-PPAR agonists",
              "GLP-1/GIP combinations (semaglutide expanding)"
            ],
            "opportunity_gaps": [
              "Cirrhosis reversal agents",
              "Pediatric NAFLD",
              "Combination sequential therapy protocols"
            ]
          },
          "key_readouts_next_18m": [
            "NASH-RESOLVE (semaglutide histology 2025)",
            "MAESTRO-NASH (lanifibranor 2025)",
            "ATLAS trial (aldafermin 2026)"
          ]
        }
      }
    },
    "schema": {
      "type": "object",
      "$schema": "https://json-schema.org/draft/2020-12/schema"
    }
  },
  "builder-code": {
    "info": {
      "a": "bc_gxy6qn5p"
    },
    "schema": {
      "type": "object",
      "$schema": "https://json-schema.org/draft/2020-12/schema",
      "properties": {
        "a": {
          "type": "string",
          "pattern": "^[a-z0-9_]{1,32}$",
          "description": "App builder code"
        },
        "s": {
          "type": "array",
          "items": {
            "type": "string",
            "pattern": "^[a-z0-9_]{1,32}$"
          },
          "description": "Service builder codes"
        },
        "w": {
          "type": "string",
          "pattern": "^[a-z0-9_]{1,32}$",
          "description": "Wallet builder code"
        }
      },
      "additionalProperties": false
    }
  }
}

Provenance

Seen in the source catalog
2026-07-01 04:26Z
Last indexed by Roundhouse
2026-07-30 16:00Z
Last enriched (probe, favicon, geo)
2026-09-11 09:45Z
x402 version
2
Max timeout
300s
Liveness probe
HTTP 402
Report

Hand this page to an agent

Copy the prompt and paste it into Claude, an MCP client or your own agent — it will vet this service and call it over the free read API. No key, no account.

GET api.roundhouseai.io/v0/endpoints

No per-endpoint history for this service yet, so this is payments indexed to its PROVIDER's wallet over 30 days. Verified volume counts only settlements with an on-chain EIP-3009 marker.

Open skill.md
Show the prompt
Using Roundhouse, look up the x402 service ClinicalIntelPulse and tell me whether it is
worth paying: what a call costs, whether the endpoint answered when last probed, and what
its payment record actually shows.

curl -s 'https://api.roundhouseai.io/v0/endpoints?q=ClinicalIntelPulse'
curl -s 'https://api.roundhouseai.io/v0/merchants/<the payTo wallet returned above>'

Then call it: read the price from the live 402 at https://clinicalintelpulse.vercel.app/api/clinical/disease-landscape, never from
a cached figure, and pay with an x402 client.

The /v0 API needs an API key (`authorization: Bearer rh_live_…`) on everything except
/v0/unified* and /v0/endpoints. Mint a personal key for $0.01 at GET https://api.roundhouseai.io/v0/test/x402,
or use an organization key from https://roundhouseai.io/dashboard/team.

If you do not have Roundhouse tools or skills installed, read
https://roundhouseai.io/skill.md first — it is the whole procedure.